Stakeholders’ Consultation Meeting
Date: 8 – 10 July 2015
Venue: World Council of Churches Geneva
Given the impending closure of African Programme for Onchocerciasis Control (APOC) and the increased commitment and momentum to control and eliminate the five neglected tropical diseases (NTDs) amenable to preventive chemotherapy (PC), several discussions have been held between WHO, partners, and endemic countries on establishing a new regional NTD entity to oversee and support accelerated efforts to control and eliminate the five PC NTDs, namely Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Soil Transmitted Helminthiasis and Trachoma.
Working closely with partners, WHO developed a proposal on the establishment of the new regional NTD entity indicating the proposed goal and objectives; scope and functions; governance structure; human resources requirements; financing mechanism; monitoring and evaluation mechanisms; accountability framework as well as budget. Furthermore, WHO with inputs from partners, developed a transition plan of action to ensure continuity of technical support to member states in the period between the closure of APOC and full establishment of the new regional NTD entity.
In April 2015, a WHO working group meeting was convened in Johannesburg to review the proposal on the establishment of the new NTD entity and the draft transition plan of action and to build consensus on the establishment of the new NTD entity. The working group meeting agreed that the new NTD entity will be a special project of the WHO/AFRO NTD programme which will be under the office of the Director, Programme Management (DPM). It will address all five (5) PC-NTDs and function as the technical arm of the AFRO NTD programme. Consensus was also reached on the functions, institutional framework, financing mechanisms, and financial accountability among others. The World Bank was identified as the fiscal agent to manage the pooled funding for the entity.
Regarding the transition plan of action, the working group meeting agreed that the plan should focus on maintaining the current level of mass drug administration (MDA) for onchocerciasis in all APOC supported countries; provision of technical support for scaling up MDA especially for lymphatic filariasis (LF); epidemiological and entomological surveillance in countries contemplating stopping community-directed treatment with ivermectin (CDTI) and MDA; activities to finalize the establishment of the new NTD entity; and ensuring the necessary funding and logistic environment for the new entity. Consensus was also reached on the core human resources needs and budget range for the transition period.
The Framework for the Special PC-NTD project and the transition plan of action have been finalized based on the above consensus reached in the Johannesburg working group meeting.
14th International Dengue Course
Date: 10–21 August 2015
Venue: Havana, Cuba
Participants will discuss updated aspects of dengue control, including progress made in vaccine and antiviral development and . The course is supported by WHO and the sessions will be held in Spanish and English. http://instituciones.sld.cu/ipk/14thdenguecourse/
Workshop on surveillance and control of rabies
Date: 26 October–7 November 2015
Venue: Pasteur Institute, Phnom Penh, Cambodia
Global conference on rabies: Global elimination of dog-mediated human rabies
Date: 10–11 December 2015
Venue: Geneva, Switzerland